|Catalog Number||Pack Size||List Price*||Quantity|
* CHF, excl. 7.7% VAT and shipping costs
You are currently not logged in.
Please register to see prices including your discount. Registration may take up to 24h. For guest orders the standard discount of your institution will apply and discounts are visible on the order confirmation.
35% discount on MedChem product orders above CHF 1'000 !
- 1st November - 31st December 2023
- Not cumulative with the "30% off Screening Libraries Promotion"
Deferoxamine B; Deferriferrioxamine B; Deferrioxamine
Deferoxamine (Deferoxamine B) is an iron chelator (binds to Fe(III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine upregulates HIF-1α levels with good antioxidant activity. Deferoxamine also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells. Deferoxamine can be used in studies of diabetes, neurodegenerative diseases as well as anti-cancer and anti-COVID-19.
|Research Field||Cancer, Infection, Metabolic Disease, Inflammation/Immunology, Neurological Disease, Apoptosis,Autophagy,Immunology/Inflammation,Metabolic Enzyme/Protease,NF-κB,PI3K/Akt/mTOR|
|Format||Solubility: 10 mM in DMSO|
|Grade||Clinical information: Launched|
|Storage Conditions||-20°C, 3 years; 4°C, 2 years (Powder)|
|Tech. Data Sheet||View datasheet|
|Link To Supplier||http://www.medchemexpress.com|
|Shipping Details||Room Temperature|
|Material Safety Data Sheet||Download PDF|